Financial Publications
New products are the key to our company's success. This innovative strength is the driving force of our growth. In this section we present facts and figures on the company's financial position.
The Management Board
Downloads
-
-
Half-year financial report 2023/24
Pages: 26File size: 467 KB -
Quarterly statement 2023/24 q1
Pages: 8File size: 196 KB
-
-
-
Annual report 2022/23
Pages: 174File size: 5 MB -
Annual financial statements HGB 2022/23
Pages: 40File size: 285 KB -
Non-financial report 2022/23
Pages: 28File size: 304 KB -
Annual report 2022/23 short version
Pages: 24File size: 2 MB
-
-
-
Statement of cash flows 6m 2023/24
File size: 25 KB -
Statement of comprehensive income 6m 2023/24
File size: 23 KB -
Income statement 6m 2023/24
File size: 24 KB -
Statement of financial position 6m 2023/24
File size: 21 KB -
Statement of cash flows 2022/23
File size: 25 KB -
Statement of comprehensive income 2022/23
File size: 23 KB -
Income statement 2022/23
File size: 23 KB -
Statement of financial position 2022/23
File size: 25 KB
-
![Preview image of Half-year financial report 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_half_year_report_2324.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Half-year financial report 2023/24")
![Preview image of Quarterly statement 2023/24 q1]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_quarterly_statement_3m2324.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Quarterly statement 2023/24 q1")
![Preview image of Annual report 2022/23]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_annual_report_202223.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Annual report 2022/23")
![Preview image of Annual financial statements HGB 2022/23]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_annual_financial_statements_hgb_202223.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Annual financial statements HGB 2022/23")
![Preview image of Non-financial report 2022/23]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_non-financial-report_202223.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Non-financial report 2022/23")
![Preview image of Annual report 2022/23 short version]({"max":"/content/dam/med-ag/investor-relations/financial-publications/afx_annual-report_202223_short-version.pdf/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Annual report 2022/23 short version")
![Preview image of Statement of cash flows 6m 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/4_statement_of_cash_flows_6m_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of cash flows 6m 2023/24")
![Preview image of Statement of comprehensive income 6m 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/2_statement_of_comprehensive_income_6m_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of comprehensive income 6m 2023/24")
![Preview image of Income statement 6m 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/1_income_statement_6m_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Income statement 6m 2023/24")
![Preview image of Statement of financial position 6m 2023/24]({"max":"/content/dam/med-ag/investor-relations/financial-publications/3_statement_of_financial_position_6m_2324.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of financial position 6m 2023/24")
![Preview image of Statement of cash flows 2022/23]({"max":"/content/dam/med-ag/investor-relations/financial-publications/5_statement_of_cash_flows_2223.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of cash flows 2022/23")
![Preview image of Statement of comprehensive income 2022/23]({"max":"/content/dam/med-ag/investor-relations/financial-publications/statement_of_comprehensive_income_2223.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of comprehensive income 2022/23")
![Preview image of Income statement 2022/23]({"max":"/content/dam/med-ag/investor-relations/financial-publications/3_income_statement.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Income statement 2022/23")
![Preview image of Statement of financial position 2022/23]({"max":"/content/dam/med-ag/investor-relations/financial-publications/4_statement_of_financial_position_2223.xlsx/_jcr_content/renditions/cq5dam.thumbnail.319.319.png"} "Download Statement of financial position 2022/23")
Key Financial Figures
|
2022/232
|
2021/222
|
2020/212
|
||||
|---|---|---|---|---|---|---|
|
|
€m |
% |
€m |
% |
€m |
% |
|
Revenue |
2,089.3 |
100 |
1,902.8 |
100 |
1,646.8 |
100 |
|
Research and development expenses |
349.3 |
16.7 |
291.4 |
15.3 |
232.1 |
14.1 |
EBIT |
348.1
|
16.7 |
363.9 |
20.9 |
373.6 |
22.7 |
Consolidated profit3 |
292.0 |
14.0 |
295.9 |
15.6 |
237.5 |
14.4 |
|
Earnings per share4 |
3.25 |
3.29 |
2.64 |
|||
|
Dividend per share |
1.105 |
1.105 |
0.905 |
|||
|
|
|
|
|
|
|
|
|
Cash flows from operating activities |
250.9 |
188.2 |
362.7 |
|||
Cash flows from investing activities
|
-111.0 |
-148.9 |
-71.2 |
|||
|
Cash flows from financing activities |
-135.1 |
-38.2 |
-289.9 |
|||
|
|
|
|
|
|
|
|
Total assets
|
3,032.9 |
100 |
2,822.8 |
100 |
2,396.0 |
100 |
|
Property, plant and equipment |
315.8 |
10.4 |
236.4 |
8.4 |
199.6 |
8.3 |
|
Equity |
2,172.9 |
71.6 |
2,030.1 |
71.9 |
1,677.4 |
70.0 |
|
Net cash6 |
863.9 |
28.5 |
885.6 |
30.3 |
939.9 |
39.2 |
|
|
|
|
|
|
|
|
|
Employees at end of reporting period (30 September) |
4,823 |
4,224 |
3,531 |
|||
![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.100.56.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.360.203.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/financial-calendar/ipad_annual_general_meeting_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/ipad_annual_general_meeting_980x308.jpg"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.100.56.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.360.203.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/searching_of_documents_bunt_980x308.jpg/_jcr_content/renditions/original.image_file.548.308.216,0,764,308.file/searching_of_documents_bunt_980x308.jpg"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.100.56.1,0,1765,992.file/archive.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.360.203.1,0,1765,992.file/archive.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.768.432.1,0,1765,992.file/archive.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1024.576.1,0,1765,992.file/archive.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1280.720.1,0,1765,992.file/archive.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1440.810.1,0,1765,992.file/archive.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/archive/archive.jpg/_jcr_content/renditions/original.image_file.1764.992.1,0,1765,992.file/archive.jpg"})
-
1
Ending 30 September
-
2
Consolidated figures according to IFRS
-
3
Before non-controlling interests
-
4
Earnings/(loss) per share attributable to the shareholders of the parent company in the fiscal year
-
5
Amount by the Supervisory Board and the Management Board of Carl Zeiss Meditec AG
-
6
Cash and cash equivalents plus treasury receivables from/payables to the treasury of Carl Zeiss AG